checkAd

IGEA Pharma N.V. IGEA to get SIX approval to the semi-annual 2022 report disclosure

IGEA Pharma N.V. / Key word(s): Annual Results/Annual Results
IGEA Pharma N.V.: IGEA to get SIX approval to the semi-annual 2022 report disclosure

30-Sep-2022 / 00:10 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


 

IGEA to get SIX approval to the semi-annual 2022  report disclosure

 

Hoofddorp, the Netherlands, 30 September 2022. IGEA Pharma N.V. (SIX: IGPH) today announced the grant of a temporary exemption from its disclosure obligations with respect to the half year 2022  report.

 

In accordance with our statutory auditors, considering that we will publish the 2021 annual report in the next days, it will be unusual to  publish the half year 2022 report before the publication of the 2021 annual report.

 

In accordance with SIX’s approval, this press release sets out the relevant section of the decision:

 

I.  The exemption application of IGEA (Issuer) dated 29 September 2022 requesting an
extension of the deadline to publish its semi-annual 2022 annual report and to file such report with SIX Exchange Regulation AG until 31 October 2022 at the latest is granted with the following reservation (lit. a and b) and under the following conditions (lit. c):

 

  1. SIX Exchange Regulation AG reserves the right to suspend trading of the registered shares of the Issuer in case its 2022 semi-annual report is not published in accordance with the provisions on ad hoc publicity (Art. 53 of the Listing Rules [LR] in connection with the Directive on Ad hoc Publicity [DAH]) and not filed with SIX Exchange Regulation AG until Monday, 31 October 2022, 11.59 pm CET, at the latest.

  

Seite 1 von 4


Wertpapier



0 Kommentare
Nachrichtenquelle: EQS Group AG
 |  108   |   |   

Schreibe Deinen Kommentar

Disclaimer

IGEA Pharma N.V. IGEA to get SIX approval to the semi-annual 2022 report disclosure IGEA Pharma N.V. / Key word(s): Annual Results/Annual Results IGEA Pharma N.V.: IGEA to get SIX approval to the semi-annual 2022 report disclosure 30-Sep-2022 / 00:10 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is …

Nachrichten des Autors

236 Leser
216 Leser
163 Leser
145 Leser
143 Leser
134 Leser
119 Leser
117 Leser
108 Leser
107 Leser
730 Leser
390 Leser
377 Leser
376 Leser
368 Leser
356 Leser
335 Leser
324 Leser
317 Leser
312 Leser
1026 Leser
732 Leser
730 Leser
708 Leser
642 Leser
639 Leser
552 Leser
495 Leser
474 Leser
442 Leser
2317 Leser
2237 Leser
2227 Leser
2225 Leser
2200 Leser
2108 Leser
1848 Leser
1800 Leser
1693 Leser
1629 Leser